Skip to main content

Alkeus Pharmaceuticals

Cambridge, United States

Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.

$150.0M raised
Jun 2023
Series B

Top Investors

Wellington ManagementMassChallengeSofinnova InvestmentsBain Capital Life SciencesTCG Crossover

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alkeus Pharmaceuticals

How much funding has Alkeus Pharmaceuticals raised?
Alkeus Pharmaceuticals has raised $150.0M in total funding. The most recent round was Series B. The last funding was announced in June 2023.
Who are Alkeus Pharmaceuticals's investors?
Alkeus Pharmaceuticals's investors include Wellington Management, MassChallenge, Sofinnova Investments, Bain Capital Life Sciences, TCG Crossover.
Where is Alkeus Pharmaceuticals headquartered?
Alkeus Pharmaceuticals is headquartered in Cambridge, United States.
What does Alkeus Pharmaceuticals do?
Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.
What stage is Alkeus Pharmaceuticals at?
Alkeus Pharmaceuticals is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Alkeus Pharmaceuticals — Funding & Investors." VCBacked, June 5, 2023, https://www.vcbacked.co/company/alkeus-pharmaceuticals. Accessed June 4, 2026.
APA
VCBacked. (2023). Alkeus Pharmaceuticals — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/alkeus-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Alkeus Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/alkeus-pharmaceuticals |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .